Sapphire Primary Care Developments is part of the Celesio AG Group, the leading European pharmaceutical wholesaler and community pharmacy retailer, with an annual turnover in excess of €22 billion.
We have the unique advantage of being part of a large healthcare organisation which brings unrivalled benefits. Our team, many of whom have joined us with NHS backgrounds, have access to current primary care clinical information which is vital if we are to develop premises which will be operational into the future provision of primary care in the community.
Due to the size of our parent company Celesio, financial security is certain which is an important factor to consider given that our clients will rely on their chosen private partner to fund the capital of the project.
With the benefit and backing from our network of healthcare organisations, Sapphire is well placed to provide the highest standard of premises in the primary care market.